Melatonin Metabolism Pathway
Melatonin is primarily metabolized in the liver through hydroxylation by cytochrome P450 enzymes, with CYP1A2 being the main enzyme responsible for converting melatonin to 6-hydroxymelatonin, which is then conjugated with sulfate and excreted in urine as 6-sulfatoxymelatonin. 1, 2
Primary Metabolic Pathway
The metabolism of melatonin follows a clear enzymatic pathway:
Hepatic Metabolism via CYP450 Enzymes:
Main Metabolic Reactions:
- 6-Hydroxylation: The dominant pathway, converting melatonin to 6-hydroxymelatonin
- O-Demethylation: A minor pathway producing N-acetylserotonin, primarily mediated by CYP2C19 and to some extent CYP1A2 2
Phase II Metabolism:
- 6-Hydroxymelatonin undergoes conjugation with sulfate
- The resulting metabolite, 6-sulfatoxymelatonin (aMT6s), is the primary urinary metabolite of melatonin 3
Enzyme Kinetics and Specificity
The affinity and catalytic efficiency of the CYP enzymes for melatonin metabolism vary:
- CYP1A2: Km = 25.9 ± 2.47 μM, Vmax = 10.6 ± 0.32 pmol/min/pmol P450 2
- CYP1A1: Km = 19.2 ± 2.01 μM, Vmax = 6.46 ± 0.22 pmol/min/pmol P450 2
- CYP1B1: Km = 30.9 ± 3.76 μM, Vmax = 5.31 ± 0.21 pmol/min/pmol P450 2
CYP1A2 shows the highest catalytic efficiency (Vmax/Km ratio) for melatonin metabolism, confirming its role as the primary enzyme in this process 2.
Extrahepatic Metabolism
While the liver is the main site of melatonin metabolism, extrahepatic metabolism also occurs:
- CYP1B1 is expressed in various extrahepatic tissues including the intestine and cerebral cortex 2
- This enzyme contributes to local regulation of melatonin and 6-hydroxymelatonin levels in these tissues 2
- Brain homogenates from studies comparing wild-type and cyp1b1-null mice confirm CYP1B1's significant role in melatonin 6-hydroxylation 2
Clinical Implications and Drug Interactions
The metabolism of melatonin by CYP enzymes has important clinical implications:
Drug Interactions: Medications that inhibit CYP1A2 can increase melatonin levels
Potential as a Probe Drug: Melatonin has been investigated as a potential probe drug for CYP1A2 activity assessment
- A significant correlation exists between apparent clearance of melatonin and caffeine clearance (Rs = 0.75, P = 0.005) 4
Measurement and Assessment
When measuring melatonin metabolism:
- The primary urinary metabolite, 6-sulfatoxymelatonin (aMT6s), can be assessed to evaluate melatonin metabolism 3, 5
- Collection protocols are critical for accurate assessment:
Pitfalls and Caveats
Several factors can affect melatonin metabolism assessment:
Timing Variability: Melatonin levels naturally fluctuate throughout the day, with highest levels at night 5
Environmental Factors: High altitude exposure can increase melatonin metabolite levels 5
Medication Effects:
Individual Variability: Despite CYP1A2's importance in melatonin metabolism, studies have not found a clear inverse correlation between CYP1A2 activity and endogenous melatonin levels, suggesting compensatory mechanisms may exist 6
Collection Methodology: Improper collection techniques can significantly affect results, leading to misinterpretation 5
Multiple assessments are recommended to establish abnormal patterns, as single measurements can lead to incorrect conclusions 5.